Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability

Neuropharmacology

Volumn 52, Issue 3, 2007, Pages 975-984

  Zazpe, Arturo ^a   Artaiz, Inés ^a   Labeaga, Luis ^a   Lucero, María Luisa ^a   Orjales, Aurelio ^a  

^a FAES FARMA SA   (Spain)

Author keywords

5 HT1A receptor; depression; Learned helplessness; p Chlorophenylalanine; Selective serotonin reuptake inhibitor; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTIDEPRESSANT AGENT; DESIPRAMINE; FENCLONINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARGYLINE; PAROXETINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADAPTIVE BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; HYPOTHERMIA; LEARNED HELPLESSNESS; LOWER LIP; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; HELPLESSNESS, LEARNED; MALE; RATS; RATS, WISTAR; REACTION TIME; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33846872366     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.10.014     Document Type: Article

References (56)

1. Altenor A., and DeYoe E.A. The effects of DL-p-chlorophenylalanine on learned helplessness in the rat. Behav. Biol. 20 (1977) 111-115
2. Aulakh C.S., Tolliver T., Wozniak K.M., Hill J.L., and Murphy D.L. Functional and biochemical evidence for altered serotonergic function in the Fawn-Hooded rat strain. Pharmacol. Biochem. Behav. 49 (1994) 615-620
3. 2 receptor activation in rats. Behav. Neural Biol. 55 (1991) 214-226
4. Blier P., and Bouchard C. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br. J. Pharmacol. 113 (1994) 485-495
5. Borsini F., and Cesana R. Mechanism of action of flibanserin in the learned helplessness paradigm in rats. Eur. J. Pharmacol. 433 (2001) 81-89
6. 1A receptor-mediated feedback: a microdialysis study in the amygdala. J. Neurochem. 76 (2001) 1645-1653
7. A, and glutamate receptors. J. Neurosci. 21 (2001) 9917-9929
8. Cervo L., Grignaschi G., Rossi C., and Samanin R. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur. J. Pharmacol. 196 (1991) 217-222
9. Cryan J.F., O'Leary O.F., Jin S.H., Friedland J.C., Ouyang M., Hirsch B.R., Page M.E., Dalvi A., Thomas S.A., and Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc. Natl. Acad. Sci. U.S.A. 21 (2004) 8186-9191
10. D'Aquila P.S., Collu M., Gessa G.L., and Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 405 (2000) 365-373
11. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., and Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry 46 (1999) 212-220
12. 1A receptor ligands 8-OH-DPAT and ipsapirone in animal models of anxiety and depression. Drug Dev. Res. 30 (1993) 91-103
13. 1A are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur. Neuropsychopharmacology 14 (2004) 487-495
14. Edwards E., Johnson J., Anderson D., Turano P., and Henn F.A. Neurochemical and behavioral consequences of mild, uncontrollable shock: effects of PCPA. Pharmacol. Biochem. Behav. 25 (1986) 415-421
15. Gambarana C., Ghiglieri O., Taddei I., Tagliamonte A., and De Montis M.G. Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action. Behav. Pharmacol. 6 (1995) 66-73
16. 1 dopamine receptors in mediating the antidepressant effect of imipramine. Pharmacol. Biochem. Behav. 50 (1995) 147-151
17. Greenwood B., Foley T.E., Day H.E.W., Campisi J., Hammack S.H., Campeau S., Maier S.F., and Fleshner M. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 23 (2003) 2889-2898
18. Hellhammer D.H., Rea M.A., Bell M., Belkien L., and Ludwig M. Learned helplessness: effects on brain monoamines and the pituitary-gonadal axis. Pharmacol. Biochem. Behav. 21 (1984) 481-485
19. 1A receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res. 978 (2003) 177-184
20. 1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment. Eur. Neuropsychopharmacol. 11 (2001) 15-24
21. 1B mRNA levels in the rat dorsal raphe nucleus. Program No. 307.9 (2005), Society for Neuroscience, Washington, DC Abstract Viewer/Itinerary Planner
22. Koch S., Perry K.W., Nelson D.L., Conway R.G., Threlkeld P.G., and Bymaster F.P. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27 (2002) 949-959
23. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychiatry 28 (1990) 620-628
24. Lightowler S., Kennett G.A., Williamson I.J., Blackburn T.P., and Tulloch I.F. Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol. Biochem. Behav. 49 (1994) 281-285
25. Maier S.F., Grahn R.E., Kalman B.A., Sutton L.C., Wiertelak E.P., and Watkins L.R. The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. Behav. Neurosci. 107 (1993) 377-388
26. Maier S.F., Grahn R.E., and Watkins L.R. 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. Behav. Neurosci. 109 (1995) 404-412
27. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: the role of the dorsal raphe nucleus, serotonin and corticotropin-releasing factor. Neurosci. Behav. Rev. 29 (2005) 829-841
28. Marek G.J., Li A.A., and Seiden L.S. Evidence for involvement of 5-hydroxytryptamine 1A receptors in antidepressant-like drug effects on differential-reinforcement of low rate 72 second behavior. J. Pharmacol. Exp. Ther. 250 (1989) 60-71
29. Martin P., Soubrie P., and Puech A.J. Reversal of helpless behaviour by serotonin uptake blockers in rats. Psychopharmacology 101 (1990) 403-407
30. 1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav. Brain Res. 38 (1990) 135-144
31. Maudhuit C., Prévot E., Dangoumau L., Martin P., Hamon M., and Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology 130 (1997) 269-275
32. Meltzer H.Y., and Maes M. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol. Psychiatry 38 (1995) 450-457
33. 2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. J. Pharmacol. Exp. Ther. 282 (1997) 132-147
34. Millan M.J., Lejeune F., and Gobert A. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J. Psychopharmacol. 14 (2000) 114-138
35. 1A receptor in the mouse tail suspension test. Neuropsychopharmacology 29 (2004) 461-469
36. 1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur. J. Pharmacol. 372 (1999) 127-134
37. B receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats. Brain Res. 741 (1996) 240-245
38. 1A receptors labeling in mice selected as a genetic model of helplessness. Brain Res. 936 (2002) 68-75
39. 1A receptor activation. Br. J. Pharmacol. 106 (1992) 603-609
40. O'Connell M.T., and Curzon G. A comparison of the effect of 8-OH-DPAT pretreatment on different behavioural responses to 8-OH-DPAT. Eur. J. Pharmacol. 312 (1996) 137-143
41. Page M.E., Detke M.J., Lynn A.D., Kirby G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147 (1999) 162-167
42. Petty F., Kramer G., and Wilson L. Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacol. Biochem. Behav. 43 (1992) 361-367
43. Petty F., Kramer G., Wilson L., and Jordan S. In vivo serotonin release and learned helplessness. Psychiatry Res. 52 (1994) 285-293
44. Pozzi L., Invernizzi R., Garavaglia C., and Samanin R. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J. Neurochem. 73 (1999) 1051-1057
45. Seligman M.E.P., and Maier S.F. Failure to escape traumatic shock. J. Exp. Psychol. 74 (1967) 1-9
46. Sherman A.D., Sacquitne J.L., and Petty F. Specificity of the learned helplessness model of depression. Pharmacol. Biochem. Behav. 16 (1982) 449-454
47. Soubrie P., Martin P., El Mestikawy S., Thiebot M.H., Simon P., and Hamon M. The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats. Pharmacol. Biochem. Behav. 25 (1986) 1-6
48. Soubrie P., Martin P., El Mestikawy S., and Hamon M. Delayed behavioral response to antidepressant drugs following selective damage to the hippocampal noradrenergic innervation in rats. Brain Res. 437 (1987) 323-331
49. Spillmann M.K., Van der Does A.J.W., Rankin M.A., Vuolo R.D., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Hayden D., Schoenfeld D., and Fava M. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology 155 (2001) 123-127
50. Takamori K., Yoshida S., and Okuyama S. Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats. Pharmacology 63 (2001) 147-153
51. Takamori K., Yoshida S., and Okuyama S. Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci. 69 (2001) 1919-1926
52. Vicentic A., Li Q., Battaglia G., and Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur. J. Pharmacol. 346 (1998) 261-266
53. Weiss J.M., and Kilts C.D. Animal models of depression and schizophrenia. In: Nemeroff C.B., and Schatzberg A.F. (Eds). Textbook of Psychopharmacology. second ed. (1998), American Psychiatry Press 88-123
54. Willner P. The validity of animal models of depression. Psychopharmacology 83 (1984) 1-16
55. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog. Neuropsychopharmacol. Biol. Psychiatry 10 (1986) 677-690
56. 1A agonist with antipsychotic- and antiparkinsonian-like properties. Neuropharmacology 51 (2006) 129-140